Big Pharma Split Corp Class A - Asset Resilience Ratio
Big Pharma Split Corp Class A (PRM) has an Asset Resilience Ratio of 93.81% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Big Pharma Split Corp Class A short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Big Pharma Split Corp Class A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see PRM total assets.
Liquid Assets Composition Over Time
This chart breaks down Big Pharma Split Corp Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore PRM long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$29.87 Million | 93.81% |
| Total Liquid Assets | CA$29.87 Million | 93.81% |
Asset Resilience Insights
- Very High Liquidity: Big Pharma Split Corp Class A maintains exceptional liquid asset reserves at 93.81% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Big Pharma Split Corp Class A Industry Peers by Asset Resilience Ratio
Compare Big Pharma Split Corp Class A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Senvest Capital Inc.
TO:SEC |
Asset Management | 1.75% |
|
Nuveen Multi-Asset Income Fund
NYSE:NMAI |
Asset Management | 0.09% |
|
Sprott Physical Silver
TO:PSLV |
Asset Management | 99.90% |
|
Janus Henderson Group PLC
F:HDJA |
Asset Management | 18.51% |
|
Compagnie du Cambodge
PA:CBDG |
Asset Management | 0.00% |
|
Central Securities Corporation
NYSE MKT:CET |
Asset Management | 3.19% |
|
A.F.P. Habitat
SN:HABITAT |
Asset Management | 7.59% |
|
UTI Asset Management Company Limited
NSE:UTIAMC |
Asset Management | 8.10% |
Annual Asset Resilience Ratio for Big Pharma Split Corp Class A (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Big Pharma Split Corp Class A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 93.81% | CA$29.87 Million ≈ $21.61 Million |
CA$31.84 Million ≈ $23.03 Million |
-1.91pp |
| 2024-12-31 | 95.71% | CA$25.17 Million ≈ $18.21 Million |
CA$26.30 Million ≈ $19.03 Million |
+93.01pp |
| 2023-12-31 | 2.71% | CA$718.24K ≈ $519.56K |
CA$26.53 Million ≈ $19.19 Million |
-57.98pp |
| 2022-12-31 | 60.69% | CA$23.73 Million ≈ $17.16 Million |
CA$39.10 Million ≈ $28.28 Million |
-32.71pp |
| 2021-12-31 | 93.40% | CA$35.32 Million ≈ $25.55 Million |
CA$37.81 Million ≈ $27.35 Million |
-4.29pp |
| 2020-12-31 | 97.69% | CA$22.40 Million ≈ $16.21 Million |
CA$22.93 Million ≈ $16.59 Million |
+0.80pp |
| 2019-12-31 | 96.89% | CA$26.33 Million ≈ $19.05 Million |
CA$27.18 Million ≈ $19.66 Million |
-1.66pp |
| 2018-12-31 | 98.55% | CA$33.14 Million ≈ $23.98 Million |
CA$33.63 Million ≈ $24.33 Million |
+5.66pp |
| 2017-12-31 | 92.89% | CA$30.18 Million ≈ $21.83 Million |
CA$32.49 Million ≈ $23.50 Million |
-- |
About Big Pharma Split Corp Class A
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.